NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/03/2026
Voltar para busca
Dado oficial do USPTO
BLOOD CANCER UNITED
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
BLOOD CANCER UNITED
ST13
US500000097981103Classe
9, 14, 16, 18, 21, 25, 41, 42, 44
Pedido
97981103
Registro
8161820
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
41
Atualização mais recente
03/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 14, 16, 18, 21, 25, 41, 42, 44
Data de depósito
11/05/2023
Data de registro
03/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
03/03/2026
Última transação
03/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Primeiro uso
28/08/2025
Primeiro uso no comércio
28/08/2025
Código do desenho
4
Tipo de titular
54
Localização do titular
WASHINGTON, DC, US
Examinador
SHIH, SALLY
Unidade examinadora
L60
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BLOOD CANCER UNITED, INC.
The Leukemia & Lymphoma Society, Inc.
Representantes
Andrew D. Price & Paula E. Hopkins VENABLE LLP
Classificação técnica
Classes Nice
Classe 9Classe 14Classe 16Classe 18Classe 21Classe 25Classe 41Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
Downloadable electronic publicationsarticlescircularsfact sheetsinfo graphicsnewslettersslide show presentationsreportswhite papers in the field of blood cancer; downloadable podcasts in the field of blood cancer; downloadable webinars in the field of blood cancer; downloadable computer application software for mobile phones for use in accessingdownloadingviewing information in the field of blood cancer
Classe 14
Jewelrycufflinksornamental pinswristbands
Classe 16
Pens; highlighters in the nature of pens and markers; notebooks
Classe 18
Backpacks; tote bags; umbrellas
Classe 21
Water bottles sold empty; mugs; insulated mugs; tumblers for use as drinking glasses
Classe 25
T-shirts; outer jackets; hooded sweatshirts; sweatshirts; polo shirts; headwearhats and beanies
Classe 41
Educational servicesproviding online webcasts in the field of blood cancer; educational servicesproviding online instruction and training in the field of blood cancer; educational servicesconducting seminarscoursesmeetingssymposiumsconferencesscientific session meetingslecturesworkshopsall in the field of blood cancer; providing a website featuring non-downloadable videos in the field of blood cancer; educational servicesproviding web-based continuing education courses for school nursessocial workersteachersschool counselors and other school and college personnel in the field of blood cancer and blood cancer treatment
Classe 42
Providing medical and scientific research information in the field of clinical trials in the field of blood cancer; medical research services in the field of blood cancer; conducting clinical trial matching between patients with blood cancer and organizations conducting or administering clinical trials in the nature of medical research in the field of blood cancer; consulting services for othershelping others designplanimplementmanage clinical trials in the field of blood cancer
Classe 44
Providing health news and information in the field of blood cancerparticularlylinks to the websites of others; providing links to the websites of others featuring health information in the field of blood cancer
Publicações
Histórico de despachos e eventos da marca no USPTO.
41 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
03/03/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/02/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/02/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
27/01/2026
DPCC
DIVISIONAL PROCESSING COMPLETE
27/01/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/01/2026
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
24/12/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
24/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/12/2025
INCD
ITU OFFICE ACTION ISSUED FOR DIVISIONAL REQUEST
11/12/2025
IUAF
USE AMENDMENT FILED
07/11/2025
DRRR
DIVISIONAL REQUEST RECEIVED
07/11/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
07/11/2025
EISU
TEAS STATEMENT OF USE RECEIVED
07/11/2025
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/10/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
24/04/2025
EX2G
SOU EXTENSION 2 GRANTED
24/04/2025
EXT2
SOU EXTENSION 2 FILED
24/04/2025
EEXT
SOU TEAS EXTENSION RECEIVED
24/04/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
16/12/2024
EX1G
SOU EXTENSION 1 GRANTED
16/12/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/12/2024
EXT1
SOU EXTENSION 1 FILED
12/11/2024
EEXT
SOU TEAS EXTENSION RECEIVED
12/11/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
14/05/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/03/2024
PUBO
PUBLISHED FOR OPPOSITION
19/03/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/02/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/02/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/02/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2024
ALIE
ASSIGNED TO LIE
09/02/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
19/09/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/09/2023
GNRT
NON-FINAL ACTION E-MAILED
05/09/2023
CNRT
NON-FINAL ACTION WRITTEN
05/09/2023
DOCK
ASSIGNED TO EXAMINER
05/09/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
16/05/2023
NWAP
NEW APPLICATION ENTERED
15/05/2023
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BLOOD CANCER UNITED ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.